1. GPCR/G Protein MAPK/ERK Pathway
  2. Ras
  3. KRASG12C IN-2

KRASG12C IN-2 (化合物 17) 是一种口服有效的 KRASG12C 抑制剂。KRASG12C IN-2 能有效抑制小鼠体内肿瘤生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

KRASG12C IN-2 Chemical Structure

KRASG12C IN-2 Chemical Structure

CAS No. : 2706637-12-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of KRASG12C IN-2:

查看 Ras 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

KRASG12C IN-2 (compound 17) is an orally active KRASG12C inhibitor. KRASG12C IN-2 inhibits tumor growth in mice[1].

IC50 & Target

KRASG12C[1].

体外研究
(In Vitro)

KRASG12C IN-2 (0-100 nM;72 h) 抑制 MIA-PA-CA-2细胞 (KRASG12C 突变) 增殖,IC50 值为 0.44 nM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: MIA-PA-CA-2 cells (with KRASG12C mutant)
Concentration: 0-100 nM
Incubation Time: 72 h
Result: Exhibited antiproliferation activity (IC50 = 0.44 nM).
体内研究
(In Vivo)

KRASG12C IN-2 (10, 30 mg/kg; p.o.; single daily for 22 days) 抑制小鼠体内肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nude Balb/c mice (Subcutaneous transplantation model of Mia PaCa-2 cells)[1].
Dosage: 10, 30 mg/kg
Administration: Oral administration; single daily for 22 days.
Result: Inhibited tumor growth in mice, and the inhibition rates are 93.06% (dosage at 10 mg/kg) and 99.64% (dosage at 30 mg/kg), respectively.
Animal Model: Male SD rats and male CD mice[1].
Dosage: 2.0 mg/kg
Administration: i.v.; single
Result: 1.19 Pharmacokinetic Parameters of KRASG12C IN-2 in Male SD rats and Male CD mice[1].
Male SD rats Male CD mice
IV (2 mg/kg) IV (2 mg/kg)
T1/2 (h) 1.9 1.7
CL (mL/min/kg) 71.5 40.6
Vdss/Vdss, u(L/kg) 10.6/221 3.9/32.3
AUC0-last/AUCu (nM•h) 653/31.3 1297/155.6
Animal Model: Male SD rats and male CD mice[1].
Dosage: 9.8, 10.3 mg/kg
Administration: p.o.; single
Result: 1.19 Pharmacokinetic Parameters of KRASG12C IN-2 in Male SD rats and Male CD mice[1].
Male SD rats Male CD mice
PO (9.8 mg/kg) PO (10.3 mg/kg)
AUC0-last/AUCu (nM•h) 995/47.8 1422/170.6
Tmax (h) 1.5 1.0
Cmax/Cmax, u (nM) 220/10.6 431/51.7
F (%) 30.5% 21.9%
分子量

679.66

Formula

C32H35F6N7O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

KRASG12C IN-2 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
KRASG12C IN-2
目录号:
HY-153262
需求量: